Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Compare Target Date versus Index options in 401(k) plans, highlighting cost, diversification, and adaptability. Learn which fund type best fits your retirement timeline.
25,660 articlesA dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Kettle Hill Capital Management disclosed a new stake in RH, loading about 161,122 shares worth roughly $28.9 million....
Choosing between broad tech exposure and a semiconductor focus can shape your portfolio’s risk and return. This guide...
Three iShares ETFs have jumped more than 100% in 2026, led by chip-rich South Korea and Taiwan. This article breaks d...
Most investors worry about market swings and fees. The real threat hides in plain sight: a risk you aren’t thinking a...
As the calendar flips to May, many investors rethink risk. This guide shows three cryptocurrencies to unload before s...
On days when upbeat earnings flood the headlines, the Nasdaq sometimes slips instead of rallying. This article explai...
When romance hits the headlines, money often follows in unexpected ways. This article breaks down practical money tip...
When a mid-sized advisory firm increases its stake in an international equity ETF, it can reveal a fresh take on glob...
If president donald trump just signals a major crypto push, investors face a fast-moving regulatory landscape. This g...
Markets wobble as investors weigh ongoing AI-driven growth against macro and policy risks, highlighting wall street’s...
A leading investment fund recently opened a sizable stake in STGW after marquee client wins. Here’s what this move co...